The world faces a peculiar problem of overuse of antibiotics, leading to drug resistance, even as some regions are unable to even access these medicines. The problem overarches human use and misuse of antibiotics, besides use in agriculture, farm animals and so. In its latest report on antimicrobial resistance (AMR), the Foundation reviews 17 global drug companies that make and supply these products and their practices.

ATM Foundation CEO, Jayasree Iyer gives us a snapshot into the work being done by drugmakers in curbing AMR, including efforts by Indian companies Aurobindo, Sun Pharma, Cipla, and Alkem in bringing in better practices in the manufacture, supply, promotion, and surveillance of these drugs.